FT4, ELISA, 96 tests

The principle of the following enzyme immunoassay test follows the typical competitive binding scenario. Competition occurs between an unlabeled antigen (present in calibrators, control and patient samples) and an enzyme-labelled antigen (conjugate) for a limited number of antibody binding sites on the microwell plate. The washing and decanting procedures remove unbound materials. After the washing step, the enzyme substrate is added. The enzymatic reaction is terminated by addition of the stopping solution. The absorbance is measured on a microtiter plate reader. The intensity of the colour formed is inversely proportional to the concentration of fT4 in the sample. A set of calibrators is used to plot a calibration curve from which the amount of fT4 in patient samples and controls can be directly read.The labeled T4 (conjugate) employed in this assay system has shown no binding properties towards thyroxine-binding globulin (TBG) and human serum albumin (HSA). The binding sites on the microwell plates are designed to be of a low binding-capacity in order not to disturb the equilibrium between T4 and its carrying proteins. The assay is carried out under normal physiological conditions of pH, temperature and ionic strength.

Catalog # KAPDB4340
Format ELISA
Label HRP
Size 96 tests
Sample Type Serum
Sample Volume 25 µL
Controls 1 level
Range 2-95 pg/mL
Sensitivity 1 pg/mL
Incubation 60/15 min. at 37°C

Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: regulatory.affairs@diasource.be.

Documents - Download
Download "Instructions for Use" KAPDB4340.pdf
Download "Material Safety Data Sheet" MSKAPDB4340.pdf
Download catalogue "ELISA" CATE.pdf
Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.